96 related articles for article (PubMed ID: 18366447)
21. Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer.
Ripamonti D; Cattaneo D; Maggiolo F; Airoldi M; Frigerio L; Bertuletti P; Ruggeri M; Suter F
AIDS; 2007 Nov; 21(18):2409-15. PubMed ID: 18025877
[TBL] [Abstract][Full Text] [Related]
22. Delaying maternal NVP-based ART more effective.
Alcorn K
IAPAC Mon; 2007 Jan; 13(1):11-2. PubMed ID: 17523244
[No Abstract] [Full Text] [Related]
23. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin.
Avihingsanon A; Manosuthi W; Kantipong P; Chuchotaworn C; Moolphate S; Sakornjun W; Gorowara M; Yamada N; Yanai H; Mitarai S; Ishikawa N; Cooper DA; Phanuphak P; Burger D; Ruxrungtham K
Antivir Ther; 2008; 13(4):529-36. PubMed ID: 18672531
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and oxidation of 2-hydroxynevirapine, a metabolite of the HIV reverse transcriptase inhibitor nevirapine.
Antunes AM; Novais DA; da Silva JL; Santos PP; Oliveira MC; Beland FA; Marques MM
Org Biomol Chem; 2011 Oct; 9(22):7822-35. PubMed ID: 21969039
[TBL] [Abstract][Full Text] [Related]
26. Are plasma levels valid surrogates for cellular concentrations of antiretroviral drugs in HIV-infected patients?
Colombo S; Telenti A; Buclin T; Furrer H; Lee BL; Biollaz J; Decosterd LA;
Ther Drug Monit; 2006 Jun; 28(3):332-8. PubMed ID: 16778716
[TBL] [Abstract][Full Text] [Related]
27. Nevirapine misinformation: will it kill?
James JS
IAPAC Mon; 2004 Dec; 10(12):450-4. PubMed ID: 15892199
[TBL] [Abstract][Full Text] [Related]
28. Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine.
Flys TS; Mwatha A; Guay LA; Nakabiito C; Donnell D; Musoke P; Mmiro F; Jackson JB; Eshleman SH
AIDS; 2007 Oct; 21(15):2077-82. PubMed ID: 17885298
[TBL] [Abstract][Full Text] [Related]
29. Switching from suppressive protease inhibitor-based regimens to nevirapine-based regimens: a meta-analysis of randomized controlled trials.
Ena J; Leach A; Nguyen P
HIV Med; 2008 Oct; 9(9):747-56. PubMed ID: 18651856
[TBL] [Abstract][Full Text] [Related]
30. Resistance to antiretrovirals in HIV-infected pregnant women.
Weinberg A; Forster-Harwood J; McFarland EJ; Pappas J; Davies JK; Kinzie K; Barr EA; Paul SM; Salbenblatt CR; Soda E; Vazquez A; Levin MJ
J Clin Virol; 2009 May; 45(1):39-42. PubMed ID: 19329355
[TBL] [Abstract][Full Text] [Related]
31. Mutations correlated to NVP concentrations.
AIDS Patient Care STDS; 2004 Aug; 18(8):489-90. PubMed ID: 15354307
[No Abstract] [Full Text] [Related]
32. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
American Academy of Pediatrics Committee on Pediatric AIDS
Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995
[TBL] [Abstract][Full Text] [Related]
33. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.
; Arrivé E; Chaix ML; Nerrienet E; Blanche S; Rouzioux C; Coffie PA; Kruy Leang S; McIntyre J; Avit D; Srey VH; Gray G; N'Dri-Yoman T; Diallo A; Ekouévi DK; Dabis F
AIDS; 2009 Apr; 23(7):825-33. PubMed ID: 19307941
[TBL] [Abstract][Full Text] [Related]
34. Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individuals.
Almond LM; Edirisinghe D; Dalton M; Bonington A; Back DJ; Khoo SH
Clin Pharmacol Ther; 2005 Aug; 78(2):132-42. PubMed ID: 16084848
[TBL] [Abstract][Full Text] [Related]
35. Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
Agmon-Levin N; Elbirt D; Asher I; Torten D; Cohen Y; Gradestein S; Werner B; Turner D; Chowers M; Gottesman G; Maayan S; Risenberg K; Levi I; Sthoeger Z
Int J STD AIDS; 2009 Jul; 20(7):473-6. PubMed ID: 19541889
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics, safety and efficacy of saquinavir/ ritonavir 1,000/100 mg twice daily as HIV type-1 therapy and transmission prophylaxis in pregnancy.
von Hentig N; Nisius G; Lennemann T; Khaykin P; Stephan C; Babacan E; Staszewski S; Kurowski M; Harder S; Haberl A
Antivir Ther; 2008; 13(8):1039-46. PubMed ID: 19195329
[TBL] [Abstract][Full Text] [Related]
37. Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria.
Naniche D; Lahuerta M; Bardaji A; Sigauque B; Romagosa C; Berenguera A; Mandomando I; David C; Sanz S; Aponte J; Ordi J; Alonso P; Menendez C
HIV Med; 2008 Oct; 9(9):757-64. PubMed ID: 18651857
[TBL] [Abstract][Full Text] [Related]
38. Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis.
Autar RS; Wit FW; Sankote J; Mahanontharit A; Anekthananon T; Mootsikapun P; Sujaikaew K; Cooper DA; Lange JM; Phanuphak P; Ruxrungtham K; Burger DM
Antivir Ther; 2005; 10(8):937-43. PubMed ID: 16430199
[TBL] [Abstract][Full Text] [Related]
39. Pathology of placenta in HIV infection.
D'costa GF; Khadke K; Patil YV
Indian J Pathol Microbiol; 2007 Jul; 50(3):515-9. PubMed ID: 17883121
[TBL] [Abstract][Full Text] [Related]
40. Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics.
Capparelli EV; Aweeka F; Hitti J; Stek A; Hu C; Burchett SK; Best B; Smith E; Read JS; Watts H; Nachman S; Thorpe EM; Spector SA; Jimenez E; Shearer WT; Foca M; Mirochnick M; ;
HIV Med; 2008 Apr; 9(4):214-20. PubMed ID: 18366444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
